ENTELLUS MED INC's ticker is ENTL and the CUSIP is 29363K105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $77,560,000 | +30.0% | 3,231,656 | 0.0% | 14.02% | +32.5% |
| Q3 2017 | $59,656,000 | +11.5% | 3,231,656 | 0.0% | 10.58% | +9.4% |
| Q2 2017 | $53,516,000 | +20.0% | 3,231,656 | 0.0% | 9.68% | -4.9% |
| Q1 2017 | $44,597,000 | -38.3% | 3,231,656 | -15.3% | 10.18% | -38.3% |
| Q4 2016 | $72,336,000 | -14.5% | 3,813,197 | 0.0% | 16.50% | -6.3% |
| Q3 2016 | $84,577,000 | +21.4% | 3,813,197 | 0.0% | 17.60% | +0.3% |
| Q2 2016 | $69,667,000 | +0.4% | 3,813,197 | 0.0% | 17.55% | -3.3% |
| Q1 2016 | $69,362,000 | +7.9% | 3,813,197 | 0.0% | 18.15% | +54.4% |
| Q4 2015 | $64,291,000 | -6.4% | 3,813,197 | 0.0% | 11.76% | -6.4% |
| Q3 2015 | $68,714,000 | -30.3% | 3,813,197 | 0.0% | 12.56% | -29.5% |
| Q2 2015 | $98,647,000 | +18.1% | 3,813,197 | +0.0% | 17.80% | +7.5% |
| Q1 2015 | $83,509,000 | – | 3,813,196 | – | 16.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,956,456 | $72,109,000 | 38.09% |
| Essex Woodlands Management, Inc. | 3,231,656 | $77,560,000 | 14.02% |
| Sand Grove Capital Management LLP | 1,364,163 | $33,627,000 | 7.25% |
| Archon Capital Management LLC | 572,804 | $13,971,000 | 7.00% |
| First Light Asset Management, LLC | 670,904 | $16,363,000 | 4.49% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 341,468 | $8,325,000 | 2.94% |
| Aisling Capital LLC | 528,655 | $12,894,000 | 2.55% |
| Cypress Capital Management LLC (WY) | 59,490 | $1,451,000 | 1.64% |
| Endurant Capital Management LP | 189,268 | $4,616,000 | 1.41% |
| HAVENS ADVISORS LLC | 69,028 | $1,684,000 | 1.27% |